Copy For Citation
ATALAR B., Ozsahin M., Call J., Napieralska A., Kamer S., Villa S., ...More
RADIOTHERAPY AND ONCOLOGY, vol.127, no.1, pp.96-102, 2018 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
127
Issue:
1
-
Publication Date:
2018
-
Doi Number:
10.1016/j.radonc.2017.12.028
-
Journal Name:
RADIOTHERAPY AND ONCOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.96-102
-
Keywords:
Adult medulloblastoma, Chemotherapy, Craniospinal, Multimodality, Radiotherapy, Rare Cancer Network (RCN), NONMETASTATIC MEDULLOBLASTOMA, ADJUVANT CHEMOTHERAPY, RISK MEDULLOBLASTOMA, SURVIVAL, MULTICENTER, RECURRENCE, STRATEGY
-
Gazi University Affiliated:
Yes
Abstract
Background and purpose: The optimal treatment for adults with newly diagnosed medulloblastoma (MB) has not been defined. We report a large series of cases from the Rare Cancer Network.